Avedana Medicated Chest Rub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to the muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For children under 2 years of age, it is advised to consult a healthcare professional prior to using this product.

For adults and children aged 2 years and older, a thick layer of the product should be applied to the throat and chest, or directly onto sore, aching muscles. If preferred, the application may be covered with a dry, soft cloth; however, it is important to ensure that clothing remains loose to allow for proper absorption and comfort.

This application may be repeated up to three times a day as needed.

Contraindications

Use of this product is contraindicated in the following situations:

Oral administration is prohibited; the product should not be taken by mouth. Additionally, it should not be applied in the nostrils, on wounds, or on damaged skin due to the potential for adverse effects. The product is also contraindicated for use with tight bandages, as this may interfere with its intended application and efficacy.

Warnings and Precautions

For external use only; contact with the eyes should be strictly avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact the Poison Control Center without delay.

No specific recommendations for discontinuation of use or additional general precautions have been provided. Additionally, there are no laboratory tests indicated for monitoring in relation to the safe use of this product.

Side Effects

Patients should be advised that the product is for external use only and must be kept away from the eyes to prevent irritation or injury.

In clinical practice, it is important to consult a healthcare professional prior to use in individuals with specific medical conditions. Patients with asthma, excessive phlegm (mucus), emphysema, persistent or chronic cough, or cough associated with smoking should seek medical advice before using this product to ensure safety and appropriateness of treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Avedana Medicated Chest Rub (camphor eucalyptus menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before using this product. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the throat and chest or on sore, aching muscles. If desired, the area may be covered with a dry soft cloth, ensuring that clothing remains loose. This application can be repeated up to three times a day.

In the event of accidental ingestion, it is crucial to seek medical assistance or contact the Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment, as individual responses may vary.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs, mental status, and any observable symptoms.

2. Supportive Care: Initiate supportive measures as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If the overdose is recent and the patient is alert, consider activated charcoal administration to limit further absorption of the substance.

4. Specific Antidotes: If applicable, administer specific antidotes as indicated for the substance involved in the overdose.

5. Monitoring: Continuous monitoring of the patient’s vital signs and clinical status is essential to detect any deterioration promptly.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on managing specific overdose cases. Additionally, reporting any adverse events or overdose incidents to the appropriate regulatory authorities is recommended to enhance the understanding of the substance's safety profile.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology. As such, a comprehensive assessment of these aspects cannot be made at this time.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center in the event of accidental ingestion of the medication. It is important for patients to understand the potential risks associated with unintentional consumption and the necessity of prompt action to ensure their safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

Patients aged 2 years and older are advised to apply a thick layer of the product to the throat and chest or to sore, aching muscles, with the option to cover the area with a dry soft cloth while ensuring clothing remains loose. This application may be repeated up to three times a day.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before using the product. In the event of accidental ingestion, patients should seek medical assistance or contact the Poison Control Center immediately. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Avedana Medicated Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)